Q2 2023 13F Holdings Report, New Holdings, Stock Holdings
Signature - Title
Tim Merrick - VP and MIM Controller
Location
Whippany, NJ
Holdings as of
June 30, 2023
Value $
$323M
Num holdings
2
Date filed
4/29/2024, 05:25 PM
Description
The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as
of the end of the calendar quarter for which the report is filed, and the total market value. The market value
column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in
accounts.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Israel Grafstein
CCO
Whippany, New Jersey
4/29/2024
This amendment adds new holdings entries of securities that were inadvertently omitted in the 13F filed for this quarter, as amended by the 13F amendment filed on April 29, 2024. Please note that this 13F Holdings Report filer is affiliated with Metropolitan Life Insurance Company and Provida Pension Fund Administrator who also file 13F Holdings Reports. Each entity files its own 13F Holdings Report because each entity has investment discretion over certain 13(f) securities reported. All three 13F Holdings Report filers are under common control of their ultimate parent, MetLife, Inc., who files a 13F Combination Report.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.